Your browser doesn't support javascript.
loading
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer.
Singh, Sonia; Jaigirdar, Adnan A; Mulkey, Flora; Cheng, Joyce; Hamed, Salaheldin S; Li, Yangbing; Liu, Jiang; Zhao, Hong; Goheer, Anwar; Helms, Whitney S; Wang, Xing; Agarwal, Rajiv; Pragani, Rajan; Korsah, Kwadwo; Tang, Shenghui; Leighton, John; Rahman, Atiqur; Beaver, Julia A; Pazdur, Richard; Theoret, Marc R; Singh, Harpreet.
Afiliação
  • Singh S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. sonia.singh@fda.hhs.gov.
  • Jaigirdar AA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Mulkey F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Cheng J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Hamed SS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Li Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Liu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Zhao H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Goheer A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Helms WS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Wang X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Agarwal R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Pragani R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Korsah K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Leighton J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Rahman A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Singh H; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Clin Cancer Res ; 27(9): 2378-2382, 2021 05 01.
Article em En | MEDLINE | ID: mdl-33288660

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbolinas / Aprovação de Drogas / Carcinoma de Pequenas Células do Pulmão / Compostos Heterocíclicos de 4 ou mais Anéis / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbolinas / Aprovação de Drogas / Carcinoma de Pequenas Células do Pulmão / Compostos Heterocíclicos de 4 ou mais Anéis / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article